Literature DB >> 24995943

Synthesis and immunological effects of heroin vaccines.

Fuying Li1, Kejun Cheng, Joshua F G Antoline, Malliga R Iyer, Gary R Matyas, Oscar B Torres, Rashmi Jalah, Zoltan Beck, Carl R Alving, Damon A Parrish, Jeffrey R Deschamps, Arthur E Jacobson, Kenner C Rice.   

Abstract

Three haptens have been synthesized with linkers for attachment to carrier macromolecules at either the n class="Chemical">piperidino-nitrogen or via an introduced 3-amino group. Two of the haptens, with a 2-oxopropyl functionality at either C6, or at both the C3 and C6 positions on the 4,5-epoxymorphinan framework, as well as the third hapten (DiAmHap) with diamido moieties at both the C3 and C6 positions, should be much more stable in solution, or in vivo in a vaccine, than a hapten with an ester in one of those positions, as found in many heroin-based haptens. A "classical" opioid synthetic scheme enabled the formation of a 3-amino-4,5-epoxymorphinan which could not be obtained using palladium chemistry. Our vaccines are aimed at the reduction of the abuse of heroin and, as well, at the reduction of the effects of its predominant metabolites, 6-acetylmorphine and morphine. One of the haptens, DiAmHap, has given interesting results in a heroin vaccine and is clearly more suited for the purpose than the other two haptens.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24995943      PMCID: PMC4146676          DOI: 10.1039/c4ob01053a

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  29 in total

1.  Dynamic vaccine blocks relapse to compulsive intake of heroin.

Authors:  Joel E Schlosburg; Leandro F Vendruscolo; Paul T Bremer; Jonathan W Lockner; Carrie L Wade; Ashlee A K Nunes; G Neil Stowe; Scott Edwards; Kim D Janda; George F Koob
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

2.  Liposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogs.

Authors:  Gary R Matyas; Alexander V Mayorov; Kenner C Rice; Arthur E Jacobson; Kejun Cheng; Malliga R Iyer; Fuying Li; Zoltan Beck; Kim D Janda; Carl R Alving
Journal:  Vaccine       Date:  2013-04-23       Impact factor: 3.641

3.  Highly enantioselective transfer hydrogenation of alpha,beta-unsaturated ketones.

Authors:  Nolwenn J A Martin; Benjamin List
Journal:  J Am Chem Soc       Date:  2006-10-18       Impact factor: 15.419

4.  Decoration of the aromatic ring of dihydrocodeinone (hydrocodone) and 14-hydroxydihydrocodeinone (oxycodone).

Authors:  Michael L Wilson; Patrick J Carroll; David R Dalton
Journal:  J Org Chem       Date:  2005-08-05       Impact factor: 4.354

Review 5.  Developing a vaccine against multiple psychoactive targets: a case study of heroin.

Authors:  G Neilm Stowe; Joel E Schlosburg; Leandro F Vendruscolo; Scott Edwards; Kaushik K Misra; Gery Schulteis; Joseph S Zakhari; George F Koob; Kim D Janda
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-12       Impact factor: 4.388

6.  Selective effects of a morphine conjugate vaccine on heroin and metabolite distribution and heroin-induced behaviors in rats.

Authors:  M D Raleigh; M Pravetoni; A C Harris; A K Birnbaum; P R Pentel
Journal:  J Pharmacol Exp Ther       Date:  2012-12-07       Impact factor: 4.030

7.  A novel bivalent morphine/heroin vaccine that prevents relapse to heroin addiction in rodents.

Authors:  Benito Anton; Philippe Leff
Journal:  Vaccine       Date:  2006-02-08       Impact factor: 3.641

8.  A morphine conjugate vaccine attenuates the behavioral effects of morphine in rats.

Authors:  Therese A Kosten; Xiaoyun Y Shen; Patrick W O'Malley; Berma M Kinsey; Ernest D Lykissa; Frank M Orson; Thomas R Kosten
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-06-02       Impact factor: 5.067

9.  Co-administration of morphine and oxycodone vaccines reduces the distribution of 6-monoacetylmorphine and oxycodone to brain in rats.

Authors:  M Pravetoni; M D Raleigh; M Le Naour; A M Tucker; T M Harmon; J M Jones; A K Birnbaum; P S Portoghese; P R Pentel
Journal:  Vaccine       Date:  2012-05-11       Impact factor: 3.641

10.  Injection route and TLR9 agonist addition significantly impact heroin vaccine efficacy.

Authors:  Paul T Bremer; Joel E Schlosburg; Jenny M Lively; Kim D Janda
Journal:  Mol Pharm       Date:  2014-02-19       Impact factor: 4.939

View more
  10 in total

Review 1.  Conjugate Vaccine Immunotherapy for Substance Use Disorder.

Authors:  Paul T Bremer; Kim D Janda
Journal:  Pharmacol Rev       Date:  2017-07       Impact factor: 25.468

2.  Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriers.

Authors:  Rashmi Jalah; Oscar B Torres; Alexander V Mayorov; Fuying Li; Joshua F G Antoline; Arthur E Jacobson; Kenner C Rice; Jeffrey R Deschamps; Zoltan Beck; Carl R Alving; Gary R Matyas
Journal:  Bioconjug Chem       Date:  2015-06-05       Impact factor: 4.774

Review 3.  Biologics to treat substance use disorders: Current status and new directions.

Authors:  Marco Pravetoni
Journal:  Hum Vaccin Immunother       Date:  2016-07-21       Impact factor: 3.452

4.  A Stable Heroin Analogue That Can Serve as a Vaccine Hapten to Induce Antibodies That Block the Effects of Heroin and Its Metabolites in Rodents and That Cross-React Immunologically with Related Drugs of Abuse.

Authors:  Agnieszka Sulima; Rashmi Jalah; Joshua F G Antoline; Oscar B Torres; Gregory H Imler; Jeffrey R Deschamps; Zoltan Beck; Carl R Alving; Arthur E Jacobson; Kenner C Rice; Gary R Matyas
Journal:  J Med Chem       Date:  2017-12-29       Impact factor: 7.446

5.  Synthesis of Potential Haptens with Morphine Skeleton and Determination of Protonation Constants.

Authors:  István Köteles; Károly Mazák; Gergő Tóth; Boglárka Tűz; Sándor Hosztafi
Journal:  Molecules       Date:  2020-09-02       Impact factor: 4.411

6.  Design, Synthesis, and In Vivo Evaluation of C1-Linked 4,5-Epoxymorphinan Haptens for Heroin Vaccines.

Authors:  Agnieszka Sulima; Fuying Li; Jeffrey Brian Morgan; Phong Truong; Joshua F G Antoline; Therese Oertel; Rodell C Barrientos; Oscar B Torres; Zoltan Beck; Gregory H Imler; Jeffrey R Deschamps; Gary R Matyas; Arthur E Jacobson; Kenner C Rice
Journal:  Molecules       Date:  2022-02-25       Impact factor: 4.927

7.  A Rapid Method for Direct Quantification of Antibody Binding-Site Concentration in Serum.

Authors:  Erwin G Abucayon; Connor Whalen; Oscar B Torres; Alexander J Duval; Agnieszka Sulima; Joshua F G Antoline; Therese Oertel; Rodell C Barrientos; Arthur E Jacobson; Kenner C Rice; Gary R Matyas
Journal:  ACS Omega       Date:  2022-07-19

8.  Synthesis and immunological effects of C14-linked 4,5-epoxymorphinan analogues as novel heroin vaccine haptens.

Authors:  Eugene S Gutman; Thomas C Irvin; J Brian Morgan; Rodell C Barrientos; Oscar B Torres; Zoltan Beck; Gary R Matyas; Arthur E Jacobson; Kenner C Rice
Journal:  RSC Chem Biol       Date:  2021-04-19

9.  Synthesis of a deuterated 6-AmHap internal standard for the determination of hapten density in a heroin vaccine drug product.

Authors:  Mariia Makarova; Rodell C Barrientos; Oscar B Torres; Gary R Matyas; Arthur E Jacobson; Agnieszka Sulima; Kenner C Rice
Journal:  J Labelled Comp Radiopharm       Date:  2020-09-28       Impact factor: 1.949

10.  A simple nonradioactive method for the determination of the binding affinities of antibodies induced by hapten bioconjugates for drugs of abuse.

Authors:  Oscar B Torres; Joshua F G Antoline; Fuying Li; Rashmi Jalah; Arthur E Jacobson; Kenner C Rice; Carl R Alving; Gary R Matyas
Journal:  Anal Bioanal Chem       Date:  2015-12-16       Impact factor: 4.142

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.